Insights from 2023 ESMO Annual Meeting

 

Sarcoma
10:55

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Novel Combinations in Sarcomas"

FEATURING Robin Jones
  • 246 views
  • November 13, 2023
  • 3
08:25

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Efficacy & Safety From MANTRA Study - Milademetan vs. Trabectedin in Patients With Dedifferentiated Liposarcomas"

FEATURING Robin Jones
  • 88 views
  • November 13, 2023
09:01

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Results From the MEDISARC Phase II Study of Durvalumab & Tremelimumab Compared to Doxorubicin in Patients With Advanced/Metastatic Soft Tissue Sarcoma"

FEATURING Viktor Grünwald
  • 141 views
  • October 25, 2023
  • 1